Abstract: A telematics terminal is provided. The telematics terminal includes a communication unit that is configured to receive weather information from a telematics center and a display unit that is configured to display the received weather information. In addition, a controller is configured to executed at least one item for triggering a function of purifying air inside a vehicle to be displayed when the weather information does not meet a predetermined air pollution standard.

Abstract: A dispenser capable of forming a uniform material layer and a method of fabricating an organic light emitting display device using the same are disclosed. The dispenser includes a syringe including a coating material and provided with a nozzle for ejecting the coating material to a substrate and a syringe cap for controlling a coating amount from the nozzle, a pressing unit providing a pressure for ejecting the coating material, a transporting unit for moving the syringe above, and a cap-driving unit for driving the syringe cap to control the coating amount.

Abstract: An electronic device is provided. The electronic device includes a communication interface configured to transmit a network temporary unlock request and receive a network temporary unlock approval. The electronic device also includes a processor configured to perform a network temporary unlock when the approval of the network temporary unlock is received, and release the network temporary unlock when a network temporary unlock time has expired by determining whether the network temporary unlock expiration time has come.

Abstract: A cathode active material including: a lithium manganese oxide of which primary particles has a diameter of 1 ?m or more and which has a spinel structure in which an X-ray diffraction (XRD) peak intensity ratio of I(111)/I(311) is 1.0 or more; and a boron element disposed at least one position selected from the group consisting of inside the primary particles and on surfaces of the primary particles.

Abstract: A compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney is disclosed. A pharmaceutical composition including the compound as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes is disclosed. A method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound is provided.

Abstract: A compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney is disclosed. A pharmaceutical composition including the compound as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes is disclosed. A method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound is provided.

Abstract: A nickel composite hydroxide for a lithium secondary battery represented by Formula 1 below with a small compositional variation in M: Ni1-x-y-zCoxMyMnz(OH)2??(1), where, in Formula 1, M is aluminum (Al), zirconium (Zr), titanium (Ti), magnesium (Mg), silicon (Si), or zinc (Zn), x is a number from 0 to 0.5, y is a number from 0.01 to 0.2, and z is a number from 0 to 0.5.

Abstract: A semiconductor package is presented which has a suitable structure for effectively shielding electromagnetic wave interference (EMI) in a cavity area to which a semiconductor chip is attached. The semiconductor package is assembled such that a lower substrate to which the semiconductor chip is attached is adhered to an EMI shielding & electric I/O body having various types of EMI shielding & electric I/O metal patterns by soldering. Further, the EMI shielding & electric I/O body is adhered to an upper substrate by soldering thereby simplifying assembling of the semiconductor package.

Abstract: A white porous polyester film of the present invention comprising a polyester-based monopolymer/copolymer blend, a crystalline polymer resin which is not miscible with a polyester and has a heat deformation temperature of 90° C. or higher, inorganic particles, a whitening agent, and a stabilizing agent has improved optical properties, and thus is useful as a film for use in printing, labeling, electronics, and display applications.

Abstract: Disclosed is a novel C-aryl ansa compound having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. Also provided are a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.

Abstract: The present invention relates to novel arylpiperazine-containing pyrrole 3-carboxamide derivatives of formula (I) or a pharmaceutically acceptable salt thereof which is useful for preventing or treating depressive disorders. The present invention also provides a method for preparing the arylpiperazine-containing pyrrole 3-carboxamide derivatives or the pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, and a method for preventing or treating depressive disorders.

Abstract: A positive active material, a method of preparing the same, and a lithium secondary battery including the positive active material.

Abstract: The present invention relates to a method for dual inhibition of sodium-dependent glucose cotransporter 1 (SGLT1) and sodium-dependent glucose cotransporter 2 (SGLT2) present in the intestine and kidney by using the compound of formula I or a pharmaceutically acceptable salt or a prodrug thereof: wherein ring A, ring B, X and Y have the same meanings as defined in the specification.

Abstract: A novel arylpiperazine-containing imidazole 4-carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating a depressive disorder are provided.

Abstract: A method of controlling a display of a plurality of objects according to an input related to operation of a mobile terminal is provided. The method includes changing, if an input related to operation of the mobile terminal is received when a layout including a plurality of areas in which a plurality of objects are respectively displayed is displayed, one or more of the plurality of areas corresponding to the input related to the operation of the mobile terminal, and displaying a layout including the changed areas. The input related to the operation of the mobile terminal may be a motion of the mobile terminal, a user's breath, or a gesture. If an input related to operation of the mobile terminal is detected while one of the areas constituting the layout is being touched, the remaining areas except for the touched area are rearranged.

Abstract: Disclosed is a novel C-aryl ansa compound having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. Also provided are a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.

Abstract: A dispenser capable of forming a uniform material layer and a method of fabricating an organic light emitting display device using the same are disclosed. The dispenser includes a syringe including a coating material and provided with a nozzle for ejecting the coating material to a substrate and a syringe cap for controlling a coating amount from the nozzle, a pressing unit providing a pressure for ejecting the coating material, a transporting unit for moving the syringe above, and a cap-driving unit for driving the syringe cap to control the coating amount.